Changing epidemiology of hepatocellular carcinoma in Asia

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 6, 2015, Pages 919-928

  Goh, George Boon Bee ^a,b   Chang, Pik Eu ^a,b   Tan, Chee Kiat ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Aflatoxin; Epidemiology; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Non alcoholic steatohepatitis NASH

Indexed keywords

AFLATOXIN; CANCER VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; ASIA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CHRONIC LIVER DISEASE; DIABETES MELLITUS; EPIDEMIC; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; OBESITY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; HEPATITIS C, CHRONIC; LIVER NEOPLASMS; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTOR;

AFLATOXINS; ASIA; CARCINOMA, HEPATOCELLULAR; HEPATITIS B; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS;

EID: 84945331835     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.09.007     Document Type: Review

References (94)

1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, and et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet] 2013 International Agency for Research on Cancer Lyon, France Available from: http://globocan.iarc.fr [accessed on 4.06.15]
2. IARC Hepatitis viruses IARC Monogr Eval Carcinog Risks Hum 59 1994 1-295
3. IARC Some traditional herbal medicines, some mycotoxins, naphthalene and styrene IARC Monogr Eval Carcinog Risks Hum 82 2002 1-556
4. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global Cancer statistics CA Cancer J Clin 61 2 2011 69 90
5. D.S. Chen Hepatitis B virus infection, its sequelae, and prevention in Taiwan K. Okuda, G. Ishak, Neoplasms of the liver 1987 Springer-Verlag Tokyo, Japan
6. C.M. Lee, S.N. Lu, C.S. Changchien, C.T. Yeh, T.T. Hsu, J.H. Tang, and et al. Age, gender and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection Cancer 86 7 1999 1143 1150
7. M. Mori, M. Hara, I. Wada, T. Hara, K. Yamamoto, M. Honda, and et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan Am J Epidemiol 151 2000 131 139
8. A.A. Evans, G. Chen, E.A. Ross, F.M. Shen, W.Y. Lin, and W.T. London Eight-year follow-up of the 90,000-person Haimen city cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences Cancer Epidemiol Biomarkers Prev 11 2002 369 376
9. H.I. Yang, S.N. Lu, Y.F. Liaw, S.L. You, C.A. Sun, L.Y. Wang, and et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174
10. S. Franceschi, M. Montella, J. Polesel, C. La Vecchia, A. Crispo, L. Dal Maso, and et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy Cancer Epidemiol Biomarkers Prev 15 2006 683 689
11. K.C. Hyams Risks of chronicity following acute hepatitis B virus infection: a review Clin Infect Dis 20 1995 992 1000
12. B.J. McMahon, W.L. Alward, D.B. Hall, W.L. Heyward, T.R. Bender, D.P. Francis, and et al. Acute hepatitis B virus infection: relation of age to clinical expression of disease and subsequent development of the carrier state J Infect Dis 151 4 1985 599 603
13. C.E. Stevens, R.P. Beasley, J. Tsui, and W.C. Lee Vertical transmission of hepatitis B antigen in Taiwan N Engl J Med 292 1975 771 774
14. G.L. Xia, C.B. Liu, H.L. Cao, S.L. Bi, M.Y. Zhan, C.A. Su, and et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992 Int Hepatol Commun 5 1996 62 73
15. N. Munoz, A. Lingao, J. Lao, J. Esteve, G. Viterbo, E.O. Domingo, and et al. Patterns familial transmission of HBV and the risk of developing liver cancer: a case-control study in the Philippines Int J Cancer 44 1989 981 984
16. H. Kuper, C. Hsieh, S.O. Stuver, L.A. Mucci, A. Tzonou, X. Zavitsanos, and et al. Birth order, as a proxy for age at infection, in the etiology of hepatocellular carcinoma Epidemiology 11 2000 680 683
17. J.H. Fan, J.B. Wang, Y. Jiang, W. Xiang, H. Liang, W.Q. Wei, and et al. Attributable causes of liver cancer mortality and incidence in China Asian Pac J Cancer Prev 14 12 2013 7251 7256
18. M.F. Yuen, and J.L. Hou A Chutaputti. Hepatocellular carcinoma in the Asia pacific region J Gastroenterol Hepatol 24 2009 346 353
19. S.N. Lu, W.W. Su, S.S. Yang, T.T. Chang, K.S. Cheng, J.C. Wu, and et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan Int J Cancer 119 2006 1946 1952
20. S.S. Lee, S.H. Jeong, Y.S. Byoun, S.M. Chung, M.H. Seong, H.R. Sohn, and et al. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma BMC Cancer 13 2013 335
21. M. Kumar, R. Kumar, S.S. Hissar, M.K. Saraswat, B.C. Sharma, P. Sakhuja, and et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India J Gastroenterol Hepatol 22 2007 1104 1111
22. T. Umemurai, T. Ichijo, K. Yoshizawai, E. Tanaka, and K. Kiyosawa Epidemiology of hepatocellular carcinoma in Japan J Gastroenterol 44 Suppl. 19 2009 102 107
23. P. Van Damme, J. Ward, D. Shouval, S. Wiersma, and A. Zanetti Hepatitis B vaccine S.A. Plotkin, W.A. Orenstein, P. Offit, Vaccines 6th ed. 2013 Saunders China
24. Global policy report on the prevention and control of viral hepatitis in WHO member states. World Health Organisation 2013 WHO Press Geneva Switzerland
25. X. Liang, S. Bi, W. Yang, L. Wang, G. Cui, F. Cui, and et al. Epidemiological serosurvey of hepatitis B in China -declining HBV prevalence due to hepatitis B vaccination Vaccine 27 47 2009 6550 6557
26. Y.H. Ni, M.H. Chang, L.M. Huang, H.L. Chen, H.Y. Hsu, T.Y. Chiu, and et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after universal hepatitis B vaccination Ann Intern Med 135 9 2001 769 800
27. L.W. Ang, J. Cutter, L. James, and K.T. Goh Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review Vaccine 32 2014 103 110
28. L.W. Ang, S.H. Tey, J. Cutter, L. James, and K.T. Goh Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010 J Med Virol 85 2013 583 588
29. M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, M.S. Kong, and et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group N Engl J Med 336 26 1997 1855 1859
30. M.H. Chang, S.L. You, C.J. Chen, C.J. Liu, C.M. Lee, S.M. Lin, and et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study J Natl Cancer Inst 101 2009 1348 1355
31. Y.F. Liaw, J.J.Y. Sung, W.C. Chow, G. Farrell, C.Z. Lee, H. Yuen, and et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
32. S.H. Lin, I.S. Sheen, R.N. Chien, C.M. Chu, and Y.F. Liaw Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 29 1999 971 975
33. J.J.Y. Sung, K.K.F. Tsoi, V.W.S. Wong, K.C.T. Li, and H.L.Y. Chan Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma Aliment Pharmacol Ther 28 2008 1067 1077
34. P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, Ira M. Jacobson, and et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
35. IARC Chemical agents and related occupations IARC Monogr Eval Carcinog Risks Hum 100F 2012 1-628
36. P.E. Jackson, G.S. Qian, M.D. Friesen, Y.R. Zhu, P. Lu, J.B. Wang, and et al. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry Cancer Res 61 2001 33 35
37. P.E. Jackson, S.Y. Kuang, J.B. Wang, P.T. Strickland, A. Munoz, T.W. Kensler, and et al. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients Carcinogenesis 24 10 2003 1657 1663
38. G.S. Toteja, A. Mukherjee, S. Diwakar, P. Singh, B.N. Saxena, K.K. Sinha, and et al. Aflatoxin B1 contamination of parboiled rice samples collected from different states of India: a multi-center study Food Addit Contam 23 4 2006 411 414
39. Z. Liu, J. Gao, and J. Yu Aflatoxins in stored maize and rice grains in Liaoning Province, China J Stored Prod Res 42 2006 468 479
40. K.R.N. Reddy, C.S. Reddy, and K. Muralidharan Detection of Aspergillus species and aflatoxin B1 in rice in India Food Microbiol 26 2009 27 31
41. S. Ahsan, I.A. Bhatti, M.R. Asi, H.N. Bhatti, and M.A. Sheikh Occurrence of aflatoxins in maize grains from central areas of Punjab, Pakistan Int J Agric Biol 12 4 2010 571 575
42. R.E. Omer, A. Kuijsten, A.M. Kadaru, F.J. Kok, M.O. Idris, I.M. El Khidir, and et al. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma Nutr Cancer 48 1 2004 15 21
43. Z.M. Liu, L.Q. Li, M.H. Peng, T.W. Liu, Z. Qin, Y. Guo, and et al. Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma Cancer Lett 263 2 2008 212 222
44. G.S. Qian, R.K. Ross, M.C. Yu, J.M. Yuan, Y.T. Gao, B.E. Henderson, and et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China Cancer Epidemiol Biomarkers Prev 3 1 1994 3 10
45. J.H. Williams, T.D. Phillips, P.E. Jolly, J.K. Stiles, C.M. Jolly, and D. Aggarwal Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions Am J Clin Nutr 80 5 2004 1106 1122
46. C.K. Tan, D.S.T. Lo, N.M. Law, H.S. Ng, and T.C. Chao Blood aflatoxin levels in patients with hepatocellular carcinoma in Singapore Singap Med J 36 6 1995 612 614
47. Y. Liu, C.C. Chang, G.M. Marsh, and F. Wu Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis Eur J Cancer 48 2012 2125 2136
48. J.G. Chen, P.A. Egner, D. Ng, L.P. Jacobson, A. Munoz, Y.R. Zhu, and et al. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China Cancer Prev Res (Phila) 6 2013 1038 1045
49. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J.F. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529 538
50. H. Tanaka, M. Tsuije, H. Tsutsumi, and M. Minai The present status of schistosomiasis in Japan Southeast Asian J Trop Med Public Health 15 4 1984 475 500
51. Y. Tanaka, K. Hanada, M. Mizokami, A.E. Yeo, J.W. Shih, T. Gojobori, and et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Proc Nat Acad Sci USA 99 24 2002 15584 15589
52. M.J. Tong, N. El-Farra, A.R. Reikes, and R.L. Co Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1995 1463 1466
53. H. Toyoda, T. Kumada, S. Kiriyama, Y. Sone, M. Tanikawa, Y. Hisanagaet, and et al. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976-2000 Cancer 100 2004 2415 2421
54. I. Ikai, M. Kudo, S. Arii, M. Omata, M. Kojiro, M. Sakamoto, and et al. Report of the 18th follow-up survey of primary liver cancer in Japan Hepatol Res 40 2010 1043 1059
55. H.B. El-Serag Hepatocellular carcinoma: recent trends in the United States Gastroenterology 127 2004 S27 S34
56. H. Yoshida, Y. Shiratori, M. Moriyama, Y. Arakawa, T. Ide, M. Sata, and et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT study Group. Inhibition of hepatocarcinogenesis by interferon therapy Ann Intern Med 131 3 1999 174 181
57. A.K. Singal, A. Singh, S. Jaganmohan, P. Guturu, R. Mummadi, Y.F. Kuo, and et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis Clin Gastroenterol Hepatol 8 2010 192 199
58. M. Charlton, G.T. Everson, S.L. Flamm, P. Kumar, C. Landis, R.S. Brown, and et al. Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease Gastroenterology 2015 May 15 10.1053/j.gastro.2015.05.010 pii: S0016-5085(15)00682-4. [Epub ahead of print]
59. J. Tanaka, T. Koyama, M. Mizui, S. Uchida, K. Katayama, J. Matsuo, and et al. Total numbers of undiagnosed carriers of hepatitis C and hepatitis B viruses in Japan estimated by age- and area-specific prevalence on the national scale Intervirology 54 2011 185 195
60. S. Gilmour, M. Kanda, E. Kusumi, T. Tanimoto, M. Kami, and K. Shibuya HPV vaccination programme in Japan Lancet 382 9894 2013 768
61. G.C. Farrell, V.W. Wong, and S. Chitturi NAFLD in Asia - as common and important as in the West Nat Rev Gastroenterol Hepatol 10 5 2013 307 318
62. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, P. Carucci, and et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 1 2002 134 140
63. J.M. Page, and S.A. Harrison NASH and HCC Clin Liver Dis 13 4 2009 631 647
64. E. Hashimoto, and K. Tokushige Hepatocellular carcinoma in non-alcoholic steatohepatitis: growing evidence of an epidemic? Hepatol Res 42 1 2012 1 14
65. D. Jain, N.C. Nayak, and S. Saigal Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients Eur J Gastroenterol Hepatol 24 7 2012 840 848
66. K.L. Goh, H. Razlan, J.L. Hartono, C.S. Qua, B.K. Yoong, P.S. Koh, and et al. Liver cancer in Malaysia: epidemiology and clinical presentation in a multiracial Asian population J Dig Dis 16 3 2015 152 158
67. E.J. Cho, M.S. Kwack, E.S. Jang, S.J. You, J.H. Lee, Y.J. Kim, and et al. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area Digestion 84 suppl. 1 2011 17 22
68. S. Yatsuji, E. Hashimoto, M. Tobari, M. Taniai, K. Tokushige, and K. Shiratori Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C J Gastroenterol Hepatol 24 2 2009 248 254
69. M.S. Ascha, I.A. Hanouneh, R. Lopez, T.A. Tamimi, A.F. Feldstein, and N.N. Zein The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 6 2010 1972 1978
70. Y. Kawamura, Y. Arase, K. Ikeda, Y. Seko, N. Imai, T. Hosaka, and et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma Am J Gastroenterol 107 2 2012 253 261
71. K. Michitaka, S. Nishiguchi, Y. Aoyagi, Y. Hiasa, Y. Tokumoto, M. Onji, and et al. Etiology of liver cirrhosis in Japan: a nationwide survey J Gastroenterol 45 1 2010 86 94
72. K. Tokushige, E. Hashimoto, Y. Horie, M. Taniai, and S. Higuchi Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey J Gastroenterol 46 10 2011 1230 1237
73. Y. Takuma, and K. Nouso Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review World J Gastroenterol 16 12 2010 1436 1441
74. K. Yasui, E. Hashimoto, Y. Komorizono, K. Koike, S. Arii, Y. Imai, and et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma Clin Gastroenterol Hepatol 9 5 2011 428 433
75. E. Hashimoto, S. Yatsuji, M. Tobari, M. Taniai, N. Torii, K. Tokushige, and et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis J Gastroenterol 44 suppl. 19 2009 89 95
76. K. Tokushige, E. Hashimoto, and K. Kodama Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan J Gastroenterol Hepatol 28 suppl. 4 2013 88 92
77. N. Kawada, K. Imanaka, T. Kawaguchi, C. Tamai, R. Ishihara, T. Matsunaga, and et al. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis J Gastroenterol 44 12 2009 1190 1194
78. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J Hepatol 56 6 2012 1384 1391
79. G. Vernon, A. Baranova, and Z.M. Younossi Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 3 2011 274 285
80. A. Ramachandran, and C. Snehalatha Rising burden of obesity in Asia J Obes 2010 2010
81. Asia Pacific Cohort Studies C The burden of overweight and obesity in the Asia-Pacific region Obes Rev 8 3 2007 191 196
82. A. Ramachandran, R.C. Ma, and C. Snehalatha Diabetes in Asia Lancet 375 9712 2010 408 418
83. A. Ramachandran, C. Snehalatha, A.S. Shetty, and A. Nanditha Trends in prevalence of diabetes in Asian countries World J Diabetes 3 6 2012 110 117
84. Z.M. Younossi, T. Gramlich, C.A. Matteoni, N. Boparai, and A.J. McCullough Nonalcoholic fatty liver disease in patients with type 2 diabetes Clin Gastroenterol Hepatol 2 3 2004 262 265
85. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 5 2004 1047 1053
86. K.A. McGlynn, J.L. Petrick, and W.T. London Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability Clin Liver Dis 19 2 2015 223 238
87. D. Saunders, D. Seidel, M. Allison, and G. Lyratzopoulos Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence Aliment Pharmacol Ther 31 10 2010 1051 1063
88. S.W. Oh, Y.S. Yoon, and S.A. Shin Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea national health insurance corporation Study J Clin Oncol 23 21 2005 4742 4754
89. Y. Muto, S. Sato, A. Watanabe, H. Moriwaki, K. Suzuki, A. Kato, and et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis Hepatol Res 35 3 2006 204 214
90. T. Utsunomiya, M. Okamoto, T. Kameyama, A. Matsuyama, M. Yamamoto, M. Fujiwara, and et al. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma World J Gastroenterol 14 10 2008 1553 1558
91. T. Ohki, R. Tateishi, S. Shiina, E. Goto, T. Sato, H. Nakagawa, and et al. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH Gut 58 6 2009 839 844
92. P. Wang, D. Kang, W. Cao, Y. Wang, and Z. Liu Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis Diabetes Metab Res Rev 28 2 2012 109 122
93. J. Polesel, A. Zucchetto, M. Montella, L. Dal Maso, A. Crispo, C. La Vecchia, and et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma Ann Oncol 20 2 2009 353 357
94. C.L. Chen, H.I. Yang, W.S. Yang, C.J. Liu, P.J. Chen, S.L. You, and et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan Gastroenterology 135 1 2008 111 121